Founded in 1978, Hikma is a global pharmaceutical company manufacturing and supplying high-quality generics, branded generics and specialty medicines across North America, Europe and the MENA region.
We aim to deliver consistent and profitable growth by building a leading generics and speciality pharmaceutical company.
We are one Hikma living a culture of progress and belonging, shaped by our three values: innovation, care and collaboration.
Leadership that drives progress
As global health needs evolve, our purpose continues to guide our strategy and ambition almost 50 years later. We are strengthening our capabilities, expanding our portfolio, and investing in our future, so we can continue to make a meaningful difference.
Our purpose is a promise to deliver high-quality medicines, to act with as a responsible business, and to help build a healthier future for all.
As global health needs evolve, our purpose continues to guide our strategy and ambition almost 50 years later. We are strengthening our capabilities, expanding our portfolio, and investing in our future, so we can continue to make a meaningful difference.
Our purpose is a promise to deliver high-quality medicines, to act with as a responsible business, and to help build a healthier future for all.
Hikma at a glance
825+ products
Across Injectables, Branded and Hikma Rx
29 manufacturing plants
Across North America, EU and MENA
3 R&D hubs
US, Jordan and Croatia
13 US FDA‑inspected facilities
12 EMA‑inspected facilities
9,400 empowered employees
Acting responsibly
We act responsibly by advancing health and wellbeing, empowering our people, protecting the environment, and building trust through quality in everything we do. We work in line with the standards of regulators across our markets, and we partner with healthcare providers, patient groups and communities to widen access to medicines.
Latest news
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
- Hikma appoints Umang Vohra as a Director Press Release, Corporate 09 November 2026 Hikma appoints Umang Vohra as a Director
- Hikma confirms full year 2026 Group guidance Press Release, Financial Results 05 November 2026 Hikma confirms full year 2026 Group guidance
- Hikma launches NPH Otic Solution, USP Sterile in the US, in partnership with Orbicular Press Release, Product 29 October 2026 Hikma launches NPH Otic Solution, USP Sterile in the US, in partnership with Orbicular
- Empowered at Hikma | Meet Ana Cristina Dias, Supervisor, Packaging, Hikma Portugal Story, Life at Hikma 27 October 2026 Empowered at Hikma | Meet Ana Cristina Dias, Supervisor, Packaging, Hikma Portugal